It has been shown that the long-term intake of low concentrations of curcumin delays the onset of AD while reducing tau phosphorylation and suppressing brain inflammation in amyloid precursor protein (APP)/presenilin-1 (PS1) transgenic AD mice [116]. This evidence concerns the gene MAPT and Alzheimer disease.